Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QNASL in seasonal allergic rhinitis
NCT00854360Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Mar 2009
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of beclomethasone dipropionate in seasonal allergic rhinitis (SAR) (4 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: reflective Total Nasal Symptom Score at 2 weeks. Started Mar 2009; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00854360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00854360.